Ballini Andrea, Scacco Salvatore, Boccellino Mariarosaria, Santacroce Luigi, Arrigoni Roberto
Department of Biosciences, Biotechnologies and Biopharmaceutics, Campus Universitario, University of Bari "Aldo Moro", 70125 Bari, Italy.
Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari "Aldo Moro", 70121 Bari, Italy.
Biology (Basel). 2020 Nov 25;9(12):415. doi: 10.3390/biology9120415.
Genetic and environmental factors are underlying causes of obesity and other metabolic diseases, so it is therefore difficult to find suitable and effective medical treatments. However, without a doubt, the gut microbiota-and also the bacteria present in the oral cavity-act as key factors in the development of these pathologies, yet the mechanisms have not been fully described. Certainly, a more detailed knowledge of the structure of the microbiota-composition, intra- and inter-species relationships, metabolic functions-could be of great help in counteracting the onset of obesity. Identifying key bacterial species will allow us to create a database of "healthy" bacteria, making it possible to manipulate the bacterial community according to metabolic and clinical needs. Targeting gut microbiota in clinical care as treatment for obesity and health-related complications-even just for weight loss has become a real possibility. In this topical review we provide an overview of the role of the microbiota on host energy homeostasis and obesity-related metabolic diseases, therefore addressing the therapeutic potential of novel and existing strategies (impact of nutrition/dietary modulation, and fecal microbiota transplantation) in the treatment of metabolic disease.
遗传和环境因素是肥胖及其他代谢性疾病的根本原因,因此很难找到合适且有效的医学治疗方法。然而,毫无疑问,肠道微生物群以及口腔中存在的细菌是这些疾病发展的关键因素,但其机制尚未得到充分描述。当然,更详细地了解微生物群的结构——组成、种内和种间关系、代谢功能——可能对对抗肥胖的发生有很大帮助。识别关键细菌种类将使我们能够创建一个“健康”细菌数据库,从而有可能根据代谢和临床需求来操纵细菌群落。将肠道微生物群作为肥胖及与健康相关并发症的临床治疗靶点——即使只是为了减肥——已成为一种切实可行的可能性。在这篇专题综述中,我们概述了微生物群在宿主能量稳态和肥胖相关代谢疾病中的作用,因此探讨了新型和现有策略(营养/饮食调节的影响以及粪便微生物群移植)在治疗代谢性疾病方面的治疗潜力。